LiquidCapsule Manufacturing
FDA inspection history in Tampa, Florida, 2015 to 2025
- 2
- Warning letters
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2015: one warning letter; 2024: one Form 483; 2025: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2015One warning letter, at Tampa, Florida.
- 2024–25One Form 483 and one warning letter, at Tampa, Florida.
Cited most
Across all LiquidCapsule Manufacturing observations on file
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.113(a)Control of microbiological contamination1
- 21 CFR 211.137(a)Expiration dating1
- 21 CFR 211.165(d)Testing and release for distribution1
- 21 CFR 211.22(d)Responsibilities of quality control unit1
The complete LiquidCapsule Manufacturing file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Tampa, Florida
Two warning letters and one Form 483 · 2015 to 2025 · 5 observations
Latest: Warning letter, Dec 19, 2025 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-12-19 | Warning letter Warning letter | Tampa, Florida | — | $99 |
| 2024-02-09 | 483 Form 483 | Tampa, Florida | 5 | $99 |
| 2015-05-15 | Warning letter Warning letter | Tampa, Florida | — | $99 |
Investigators on these documents
FEI number 3006676534 · most recent document Dec 19, 2025
About LiquidCapsule Manufacturing
How many FDA Form 483s has LiquidCapsule Manufacturing received?
FDA Intel has 1 Form 483 on file for LiquidCapsule Manufacturing; the most recent is dated Feb 9, 2024.
When was LiquidCapsule Manufacturing last inspected by FDA?
The most recent FDA inspection document on file for LiquidCapsule Manufacturing is a Form 483 dated Feb 9, 2024, for the site in Tampa, Florida.
What did FDA cite at LiquidCapsule Manufacturing?
The regulations cited most in the observations on file for LiquidCapsule Manufacturing are 21 CFR 211.100(a) (Written procedures; deviations), 1 time; 21 CFR 211.113(a) (Control of microbiological contamination), 1 time; 21 CFR 211.137(a) (Expiration dating), 1 time.
Has LiquidCapsule Manufacturing received an FDA warning letter?
Yes. FDA Intel has 2 FDA warning letters on file for LiquidCapsule Manufacturing; the most recent is dated Dec 19, 2025.